Chen T, Sahin A, Aldaz C M
Department of Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Smithville, Texas 78957, USA.
Cancer Res. 1996 Dec 15;56(24):5605-9.
Allelic losses or imbalances affecting chromosome arm 16q appear to be early genomic abnormalities in breast carcinogenesis, because they were observed in a significant number of breast ductal carcinoma in situ lesions in our previous study (Aldaz et al., Cancer Res., 55: 3976-3981, 1995). To define the minimum region of loss of heterozygosity (LOH), we generated a high-resolution allelotype of 35 ductal carcinoma in situ cases and completed a deletion map of chromosome 16q by means of paraffin-embedded tissue microdissection and PCR microsatellite analysis of 22 markers. We observed a strikingly high frequency of LOH in 16q, with 31 of 35 tumors (89%) affected. We identified three distinctive areas with high LOH. Two areas were described previously and correspond to 16q21 and 16q24.2-qter. The third and most commonly affected area spanned the region from marker D16S515 to marker D16S504. The most affected locus was at D16S518, in which LOH was observed in 20 of 26 informative cases (77%), and we estimate that it lies in subregion q23.3-q24.1. The region of highest LOH spanned approximately 2-3 Mb, as determined by a yeast artificial chromosome contig reported to cover this region. Such a high frequency of LOH at a preinvasive stage of breast cancer suggests that a candidate tumor suppressor gene or genes at this location may play an important role in breast carcinogenesis.
影响染色体16q臂的等位基因缺失或失衡似乎是乳腺癌发生过程中早期的基因组异常,因为在我们之前的研究中,在大量乳腺导管原位癌病变中观察到了这些情况(阿尔达兹等人,《癌症研究》,55: 3976 - 3981, 1995)。为了确定杂合性缺失(LOH)的最小区域,我们构建了35例导管原位癌的高分辨率等位基因型,并通过石蜡包埋组织显微切割和对22个标记进行PCR微卫星分析,完成了16号染色体q臂的缺失图谱。我们观察到16q上LOH的频率极高,35个肿瘤中有31个(89%)受到影响。我们确定了三个具有高LOH的独特区域。两个区域先前已有描述,分别对应于16q21和16q24.2 - qter。第三个也是最常受影响的区域跨越了从标记D16S515到标记D16S504的区域。受影响最严重的位点是D16S518,在26例信息充分的病例中有20例(77%)观察到LOH,我们估计它位于q23.3 - q24.1亚区域。根据报道覆盖该区域的酵母人工染色体重叠群确定,最高LOH区域跨度约为2 - 3 Mb。乳腺癌侵袭前阶段如此高频率的LOH表明,该位置的一个或多个候选肿瘤抑制基因可能在乳腺癌发生过程中起重要作用。